Related Experiment Video
Updated: Jun 1, 2026

06:15
Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Recurrent sclerosing Basal-cell carcinomas requiring ablative cranio facial surgery - a 3-case report
Oncology Reports
|May 21, 2011
Summary
Recurrent sclerosing basal cell carcinomas are aggressive skin cancers requiring extensive surgery. Early diagnosis and radical treatment are crucial to prevent disfiguring recurrences.
Area of Science:
- Dermatology
- Surgical Oncology
- Plastic Surgery
Background:
- Sclerosing basal cell carcinoma (sBCC) is a rare subtype of basal cell carcinoma.
- Recurrent sBCC presents significant therapeutic challenges due to its aggressive nature and potential for extensive local invasion.
Purpose of the Study:
- To highlight the aggressive behavior of recurrent facial sclerosing basal cell carcinomas.
- To emphasize the importance of early diagnosis, radical initial treatment, and lifelong follow-up for these challenging cases.
Main Methods:
- Case series reporting on three patients with facial recurrent sBCC.
- Surgical management involving extensive craniofacial resection and reconstruction with regional or free flaps.
- Histological examination for margin control.
Main Results:
- All three cases required large ablative surgeries for tumor removal.
- Reconstruction involved complex regional or free flaps.
- The aggressive nature of sBCC necessitates meticulous surgical planning and execution.
Conclusions:
- Early and aggressive management, including complete surgical excision with clear margins, is paramount for treating recurrent facial sBCC.
- Radiotherapy serves as an alternative for select cases (small lesions, non-surgical candidates).
- Close, lifelong follow-up is essential to detect and manage potential recurrences promptly, minimizing disfigurement.